Literature DB >> 35330906

Role of Complete Duplex Ultrasound to Diagnose Deep Vein Thrombosis in COVID-19 Critical Patients.

Matteo Pozzi1, Marco Giani1,2, Benedetta Fumagalli2, Mariangela Calabria1, Davide Leni1, Vittorio Segramora1, Giacomo Bellani1,2, Giuseppe Foti1,2.   

Abstract

An increased risk of deep vein thrombosis (DVT) has been reported in critical COVID-19 patients, despite adequate thromboprophylaxis, and most of DVT are probably asymptomatic. As a screening approach has been advocated, the best examination protocol is unknown. The objective of this study is to assess the role of a Complete Duplex Ultrasound (CDUS) examination in detecting DVT in a large population of COVID-19 patients admitted to intensive care unit (ICU) for respiratory failure. Single-center retrospective study of 145 COVID-19 patients admitted to ICU. DVT was assessed with a CDUS performed by experienced radiologist after ICU admission. DVT was confirmed in 38 patients (26%). Most DVT were distal to the knee (66%), while only 16% were proximal. At the time of the examination, 55% of the patients received full-dose anticoagulation, while 45% received thromboprophylaxis, and there were no differences in anticoagulation regimen between positive and negative patients. Patients with DVT had higher dimers compared with those with negative CDUS (P < .002). The observed frequency of DVT is high despite adequate anticoagulation. A comprehensive and experienced ultrasound examination protocol can allow to recognize a large number of distal DVT otherwise missed, albeit their clinical significance is unknown.
© 2021, Society for Vascular Ultrasound.

Entities:  

Keywords:  COVID-19; Doppler; anticoagulants; critical care; ultrasonography; venous thrombosis

Year:  2021        PMID: 35330906      PMCID: PMC7803790          DOI: 10.1177/1544316720985812

Source DB:  PubMed          Journal:  J Vasc Ultrasound        ISSN: 1544-3167


  11 in total

1.  Deep venous thrombosis in medical-surgical critically ill patients: prevalence, incidence, and risk factors.

Authors:  Deborah Cook; Mark Crowther; Maureen Meade; Christian Rabbat; Lauren Griffith; David Schiff; William Geerts; Gordon Guyatt
Journal:  Crit Care Med       Date:  2005-07       Impact factor: 7.598

2.  Extremely High Incidence of Lower Extremity Deep Venous Thrombosis in 48 Patients With Severe COVID-19 in Wuhan.

Authors:  Bin Ren; Feifei Yan; Zhouming Deng; Sheng Zhang; Meng Wu; Lin Cai; Lingfei Xiao
Journal:  Circulation       Date:  2020-05-15       Impact factor: 29.690

3.  DVT surveillance program in the ICU: analysis of cost-effectiveness.

Authors:  Ajai K Malhotra; Stephanie R Goldberg; Laura McLay; Nancy R Martin; Luke G Wolfe; Mark M Levy; Vishal Khiatani; Todd C Borchers; Therese M Duane; Michel B Aboutanos; Rao R Ivatury
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

4.  High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients.

Authors:  Jean-François Llitjos; Maxime Leclerc; Camille Chochois; Jean-Michel Monsallier; Michel Ramakers; Malika Auvray; Karim Merouani
Journal:  J Thromb Haemost       Date:  2020-05-27       Impact factor: 5.824

5.  Incidence of venous thromboembolism in hospitalized patients with COVID-19.

Authors:  Saskia Middeldorp; Michiel Coppens; Thijs F van Haaps; Merijn Foppen; Alexander P Vlaar; Marcella C A Müller; Catherine C S Bouman; Ludo F M Beenen; Ruud S Kootte; Jarom Heijmans; Loek P Smits; Peter I Bonta; Nick van Es
Journal:  J Thromb Haemost       Date:  2020-07-27       Impact factor: 5.824

6.  Venous thromboembolism in critically Ill patients with COVID-19: Results of a screening study for deep vein thrombosis.

Authors:  Alban Longchamp; Justine Longchamp; Sara Manzocchi-Besson; Livia Whiting; Claude Haller; Séverin Jeanneret; Manoelle Godio; Juan Jose Garcia Martinez; Thierry Bonjour; Mary Caillat; Guillaume Maitre; Julian Matthias Thaler; Rémy Pantet; Viviane Donner; Alexis Dumoulin; Stéphane Emonet; Gilbert Greub; Raymond Friolet; Helia Robert-Ebadi; Marc Righini; Bienvenido Sanchez; Julie Delaloye
Journal:  Res Pract Thromb Haemost       Date:  2020-06-30

7.  Incidence of asymptomatic deep vein thrombosis in patients with COVID-19 pneumonia and elevated D-dimer levels.

Authors:  P Demelo-Rodríguez; E Cervilla-Muñoz; L Ordieres-Ortega; A Parra-Virto; M Toledano-Macías; N Toledo-Samaniego; A García-García; I García-Fernández-Bravo; Z Ji; J de-Miguel-Diez; L A Álvarez-Sala-Walther; J Del-Toro-Cervera; F Galeano-Valle
Journal:  Thromb Res       Date:  2020-05-13       Impact factor: 3.944

8.  Thrombotic events in SARS-CoV-2 patients: an urgent call for ultrasound screening.

Authors:  Guido Tavazzi; Luca Civardi; Luca Caneva; Silvia Mongodi; Francesco Mojoli
Journal:  Intensive Care Med       Date:  2020-04-22       Impact factor: 17.440

Review 9.  COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review.

Authors:  Behnood Bikdeli; Mahesh V Madhavan; David Jimenez; Taylor Chuich; Isaac Dreyfus; Elissa Driggin; Caroline Der Nigoghossian; Walter Ageno; Mohammad Madjid; Yutao Guo; Liang V Tang; Yu Hu; Jay Giri; Mary Cushman; Isabelle Quéré; Evangelos P Dimakakos; C Michael Gibson; Giuseppe Lippi; Emmanuel J Favaloro; Jawed Fareed; Joseph A Caprini; Alfonso J Tafur; John R Burton; Dominic P Francese; Elizabeth Y Wang; Anna Falanga; Claire McLintock; Beverley J Hunt; Alex C Spyropoulos; Geoffrey D Barnes; John W Eikelboom; Ido Weinberg; Sam Schulman; Marc Carrier; Gregory Piazza; Joshua A Beckman; P Gabriel Steg; Gregg W Stone; Stephan Rosenkranz; Samuel Z Goldhaber; Sahil A Parikh; Manuel Monreal; Harlan M Krumholz; Stavros V Konstantinides; Jeffrey I Weitz; Gregory Y H Lip
Journal:  J Am Coll Cardiol       Date:  2020-04-17       Impact factor: 24.094

10.  Incidence of thrombotic complications in critically ill ICU patients with COVID-19.

Authors:  F A Klok; M J H A Kruip; N J M van der Meer; M S Arbous; D A M P J Gommers; K M Kant; F H J Kaptein; J van Paassen; M A M Stals; M V Huisman; H Endeman
Journal:  Thromb Res       Date:  2020-04-10       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.